These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 30687897)

  • 1. Individual parkinsonian motor signs and striatal dopamine transporter deficiency: a study with [I-123]FP-CIT SPECT.
    Mäkinen E; Joutsa J; Jaakkola E; Noponen T; Johansson J; Pitkonen M; Levo R; Mertsalmi T; Scheperjans F; Kaasinen V
    J Neurol; 2019 Apr; 266(4):826-834. PubMed ID: 30687897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of non-motor symptoms in unclear parkinsonism and tremor: A study with [
    Jaakkola E; Joutsa J; Mäkinen E; Noponen T; Pitkonen M; Levo R; Mertsalmi T; Scheperjans F; Kaasinen V
    J Neurol Sci; 2019 Sep; 404():124-127. PubMed ID: 31374410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it?
    Pirker W
    Mov Disord; 2003 Oct; 18 Suppl 7():S43-51. PubMed ID: 14531046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of combining
    Niimi Y; Ito S; Murate K; Hirota S; Hikichi C; Ishikawa T; Maeda T; Nagao R; Shima S; Mizutani Y; Ueda A; Mutoh T
    J Neurol Sci; 2017 Jun; 377():174-178. PubMed ID: 28477690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal FP-CIT uptake differs in the subtypes of early Parkinson's disease.
    Spiegel J; Hellwig D; Samnick S; Jost W; Möllers MO; Fassbender K; Kirsch CM; Dillmann U
    J Neural Transm (Vienna); 2007 Mar; 114(3):331-5. PubMed ID: 16715205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Extrastriatal
    Joling M; Vriend C; van den Heuvel OA; Raijmakers PGHM; Jones PA; Berendse HW; Booij J
    J Nucl Med; 2017 Jul; 58(7):1117-1123. PubMed ID: 27856628
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of 123I-FP-CIT-SPECT in the differential diagnosis of Parkinson and tremor syndromes: a critical assessment of 125 cases.
    Sixel-Döring F; Liepe K; Mollenhauer B; Trautmann E; Trenkwalder C
    J Neurol; 2011 Dec; 258(12):2147-54. PubMed ID: 21547379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early-onset drug-induced parkinsonism after exposure to offenders implies nigrostriatal dopaminergic dysfunction.
    Chung SJ; Yoo HS; Moon H; Oh JS; Kim JS; Park YH; Hong JY; Ye BS; Sohn YH; Lee PH
    J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):169-174. PubMed ID: 28912301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct FP-CIT PET patterns of Alzheimer's disease with parkinsonism and dementia with Lewy bodies.
    Chung SJ; Lee YH; Yoo HS; Sohn YH; Ye BS; Cha J; Lee PH
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1652-1660. PubMed ID: 30980099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
    Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
    J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study.
    Tinazzi M; Morgante F; Matinella A; Bovi T; Cannas A; Solla P; Marrosu F; Nicoletti A; Zappia M; Luca A; Di Stefano A; Morgante L; Pacchetti C; Minafra B; Sciarretta M; Dallocchio C; Rossi S; Ulivelli M; Ceravolo R; Frosini D; Cipriani A; Barbui C
    Schizophr Res; 2014 Feb; 152(2-3):344-9. PubMed ID: 24369987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [123I]FP-CIT SPECT in Clinically Uncertain Parkinsonism Predicts Survival: A Data-Driven Analysis.
    Frings L; Henninger F; Treppner M; Köber G; Boeker M; Hellwig S; Buchert R; Meyer PT
    J Parkinsons Dis; 2020; 10(4):1457-1465. PubMed ID: 33044193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.
    Iranzo A; Valldeoriola F; Lomeña F; Molinuevo JL; Serradell M; Salamero M; Cot A; Ros D; Pavía J; Santamaria J; Tolosa E
    Lancet Neurol; 2011 Sep; 10(9):797-805. PubMed ID: 21802993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential alterations of dopamine transporter in the striatum and midbrain in patients with parkinsonian syndrome.
    Matesan MC; Cross DJ; Lewis DH; Minoshima S
    Clin Nucl Med; 2015 Mar; 40(3):191-4. PubMed ID: 25546191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of dopaminergic function in frontotemporal dementia using I-FP-CIT single photon emission computed tomography.
    Sedaghat F; Gotzamani-Psarrakou A; Dedousi E; Arnaoutoglou M; Psarrakos K; Baloyannis I; Dimitriadis AS; Baloyannis SJ
    Neurodegener Dis; 2007; 4(5):382-5. PubMed ID: 17622781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival in Parkinson's disease in relation to striatal dopamine transporter binding.
    Mäkinen E; Joutsa J; Vahlberg T; Kaasinen V
    Parkinsonism Relat Disord; 2017 Sep; 42():66-72. PubMed ID: 28662820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in nigro-striatal impairment in clinical variants of early Parkinson's disease: evidence from a FP-CIT SPECT study.
    Rossi C; Frosini D; Volterrani D; De Feo P; Unti E; Nicoletti V; Kiferle L; Bonuccelli U; Ceravolo R
    Eur J Neurol; 2010 Apr; 17(4):626-30. PubMed ID: 20050904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkin disease.
    Varrone A; Pellecchia MT; Amboni M; Sansone V; Salvatore E; Ghezzi D; Garavaglia B; Brice A; Brunetti A; Bonavita V; De Michele G; Salvatore M; Pappatà S; Barone P
    Neurology; 2004 Dec; 63(11):2097-103. PubMed ID: 15596756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking in Patients with Parkinson's Disease: preliminary striatal DaT-SPECT findings.
    Gigante AF; Defazio G; Niccoli Asabella A; Superbo M; Ferrari C; Liuzzi D; Iliceto G; Livrea P; Rubini G
    Acta Neurol Scand; 2016 Oct; 134(4):265-70. PubMed ID: 26659996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in striatal dopamine transporter density between tremor dominant and non-tremor Parkinson's disease.
    Kaasinen V; Kinos M; Joutsa J; Seppänen M; Noponen T
    Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1931-7. PubMed ID: 24867256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.